TrialScientific reports2024

Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result.

Yaping Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.